The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Vaccines Market Research Report 2024
Synopsis
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Oral Vaccines market was valued at US$ 2474 million in 2023 and is anticipated to reach US$ 3333.6 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
Report Scope
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Oral Vaccines market was valued at US$ 2474 million in 2023 and is anticipated to reach US$ 3333.6 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
Report Scope
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Vaccines Market Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Oral Vaccines Segment by Type
1.2.1 Global Oral Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Oral Vaccines Segment by Application
1.3.1 Global Oral Vaccines Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Vaccines Revenue 2019-2030
1.4.2 Global Oral Vaccines Sales 2019-2030
1.4.3 Global Oral Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Vaccines Market Competition by Manufacturers
2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Oral Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Vaccines, Product Type & Application
2.7 Oral Vaccines Market Competitive Situation and Trends
2.7.1 Oral Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Vaccines Players Market Share by Revenue
2.7.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Vaccines Retrospective Market Scenario by Region
3.1 Global Oral Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Vaccines Global Oral Vaccines Sales by Region: 2019-2030
3.2.1 Global Oral Vaccines Sales by Region: 2019-2024
3.2.2 Global Oral Vaccines Sales by Region: 2025-2030
3.3 Global Oral Vaccines Global Oral Vaccines Revenue by Region: 2019-2030
3.3.1 Global Oral Vaccines Revenue by Region: 2019-2024
3.3.2 Global Oral Vaccines Revenue by Region: 2025-2030
3.4 North America Oral Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Vaccines Sales by Country (2019-2030)
3.4.3 North America Oral Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Vaccines Sales by Country (2019-2030)
3.5.3 Europe Oral Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Oral Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Vaccines Sales by Type (2019-2030)
4.1.1 Global Oral Vaccines Sales by Type (2019-2024)
4.1.2 Global Oral Vaccines Sales by Type (2025-2030)
4.1.3 Global Oral Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Oral Vaccines Revenue by Type (2019-2030)
4.2.1 Global Oral Vaccines Revenue by Type (2019-2024)
4.2.2 Global Oral Vaccines Revenue by Type (2025-2030)
4.2.3 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Oral Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Vaccines Sales by Application (2019-2030)
5.1.1 Global Oral Vaccines Sales by Application (2019-2024)
5.1.2 Global Oral Vaccines Sales by Application (2025-2030)
5.1.3 Global Oral Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Oral Vaccines Revenue by Application (2019-2030)
5.2.1 Global Oral Vaccines Revenue by Application (2019-2024)
5.2.2 Global Oral Vaccines Revenue by Application (2025-2030)
5.2.3 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Oral Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Oral Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Oral Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Oral Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute Oral Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Valneva Oral Vaccines Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai United Cell Oral Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bibcol Oral Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PaxVax Oral Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vabiotech Oral Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Oral Vaccines Description and Business Overview
6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Oral Vaccines Description and Business Overview
6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 EuBiologics Oral Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Oral Vaccines Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Oral Vaccines Description and Business Overview
6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bio-Med Oral Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Vaccines Industry Chain Analysis
7.2 Oral Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Vaccines Production Mode & Process
7.4 Oral Vaccines Sales and Marketing
7.4.1 Oral Vaccines Sales Channels
7.4.2 Oral Vaccines Distributors
7.5 Oral Vaccines Customers
8 Oral Vaccines Market Dynamics
8.1 Oral Vaccines Industry Trends
8.2 Oral Vaccines Market Drivers
8.3 Oral Vaccines Market Challenges
8.4 Oral Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
